Analyst Ratings February 24, 2026

Canaccord Lifts Middleby Price Target as Corporate Restructuring and Buybacks Continue

Analyst raises sum-of-the-parts target to $187 and keeps a Buy rating ahead of Q4 2025 results

By Jordan Park MIDD
Canaccord Lifts Middleby Price Target as Corporate Restructuring and Buybacks Continue
MIDD

Canaccord Genuity raised its price target on Middleby Corp to $187 from $175 and kept a Buy rating as the company executes a strategic shift toward commercial foodservice. The upgrade follows a December agreement to sell a majority stake in the Residential Kitchen business, a completed closing in February, sizeable share repurchases, and expectations for a Food Processing spin in the second quarter. Canaccord updated its estimates modestly and sees a potential replacement cycle in restaurants if traffic declines have stabilized.

Key Points

  • Canaccord Genuity raised its price target on Middleby to $187 from $175 and kept a Buy rating ahead of Q4 2025 results.
  • Middleby completed a sale of 51% of its Residential Kitchen business to 26North, receiving approximately $540 million in cash and a $135 million seller note.
  • The company repurchased 1.5 million shares for $218 million in Q4 2025 and bought an additional $152 million of stock in January; a Food Processing spin is expected in the second quarter.

Canaccord Genuity has increased its price target for Middleby Corp to $187 from $175 while maintaining a Buy recommendation, citing the company's ongoing portfolio reshaping and capital allocation moves. The update comes as Middleby prepares to report fourth-quarter 2025 results, with the company scheduled to release the numbers before the market opens on Thursday, February 26.

At the time of Canaccord's update, Middleby shares were trading at $158.15, which sits below InvestingPro's Fair Value estimate of $163.30. That gap, Canaccord suggests, leaves room for investor upside should the company's turnaround thesis play out.

Analyst rationale

Canaccord's analysis incorporated recent company results, capital expenditure and new-unit guidance reported by Middleby's restaurant customers, and commentary from industry peers. The firm highlighted a conditional scenario: if the worst of restaurant-traffic declines is behind the industry, a sizable replacement cycle could develop. In that scenario, operators may accelerate purchases of Middleby's commercial foodservice equipment, which Canaccord says can deliver rapid paybacks to buyers through reductions in waste and labor costs.

Portfolio moves and cash returns

Middleby announced in December that it had entered into a definitive agreement to sell a 51% stake in its Residential Kitchen business to 26North, with that segment valued at $885 million in the transaction. The deal closed on February 2, and Middleby received cash proceeds of approximately $540 million while retaining a $135 million seller note provided to the joint venture.

The company also repurchased 1.5 million shares for $218 million during the fourth quarter of 2025 and bought additional stock valued at $152 million in January. InvestingPro Tips noted that management's aggressive repurchases have contributed to a high shareholder yield.

With the Residential Kitchen business now in a joint venture and a Food Processing spin expected in the second quarter, Canaccord said renewed managerial focus on the commercial foodservice segment should underpin a turnaround in that core business.

Estimates and valuation

Following the corporate moves, Canaccord modestly raised its 2026 estimates and increased its sum-of-the-parts-derived price target to $187 from $175. Wall Street analysts maintain a consensus Buy rating on Middleby, which has a market valuation of $7.97 billion. Consensus forecasts reflected in that analyst community project a return to profitability, with expected earnings of $9.30 per share for fiscal 2025.

Other recent corporate developments

Beyond the 51% sale of the Residential Kitchen unit and the associated proceeds, Middleby extended a cooperation agreement with Garden Investment Management. As part of that extension, the company will include a nomination of Ed Garden for election to the board of directors at Middleby's 2026 annual meeting. The company also added Christopher Hix to its board; Hix brings prior experience as Executive Vice President and Chief Financial Officer of Enovis Corporation.

Analyst activity

In the broader analyst community, Jefferies upgraded Middleby to a Buy rating and pointed to an expected recovery in Commercial Foodservice demand as a primary catalyst for the stock. Canaccord's actions included maintaining a Buy stance and raising its price target - initially to $175 and then, following further review and the sum-of-the-parts work, to $187.


What to watch next

  • Middleby's fourth-quarter 2025 results, due before market open Thursday, February 26.
  • Timing and execution details for the Food Processing spin expected in the second quarter.
  • How the company deploys remaining proceeds and whether share repurchases continue to be a priority.

Canaccord's revised target and the company's balance-sheet actions leave Middleby positioned as a focused commercial foodservice equipment company in the view of these analysts, but upcoming earnings, the spin timetable, and end-market demand will be decisive in validating that view.

Risks

  • If restaurant traffic declines are not yet past the trough, the replacement cycle Canaccord anticipates may be delayed, affecting demand for commercial foodservice equipment - this impacts the restaurants and equipment manufacturing sectors.
  • Execution risk around the planned Food Processing spin and the integration of the Residential Kitchen joint venture could affect operational focus and financial metrics - this impacts corporate governance and industrial segments.
  • Dependence on successful redeployment of proceeds and continued share buybacks presents capital allocation risk if market or operational conditions change - this affects investor returns and equity markets.

More from Analyst Ratings

Wolfe Research Starts Coverage of Centessa, Assigns Outperform and $40 Target Feb 24, 2026 RBC Reaffirms Outperform on Neurocrine, Sees Buyout Interest as Revenue Grows Feb 24, 2026 Morgan Stanley Trims JBS Price Target but Keeps Overweight Call as Quarter Looks Resilient Feb 24, 2026 Piper Sandler Lowers Beyond Inc Price Target, Cites Integration Uncertainty Feb 24, 2026 KeyBanc Keeps Hims & Hers at Sector Weight After Q4 Results, Flags 2026 Investment Plan Feb 24, 2026